Related by context. All words. (Click for frequent words.) 81 HRQOL 78 HRQoL 75 QoL 71 psychosocial functioning 71 SGRQ 70 BMI z 70 subscales 70 EQ 5D 70 subscale scores 69 symptom severity 69 Health Assessment Questionnaire 69 IBDQ 68 neurocognitive function 68 alexithymia 68 depressive symptomatology 68 psychiatric comorbidities 67 univariate analyzes 67 MMSE score 67 psychosocial variables 67 Depressive symptoms 67 somatic symptoms 67 HAQ DI 66 logistic regression analyzes 66 APOE genotype 66 psychiatric comorbidity 66 interrater reliability 66 depressive symptom 66 EORTC QLQ C# 66 Logistic regression analysis 66 liver histology 66 comorbid conditions 66 metabolic parameters 65 Montgomery Åsberg Depression 65 NIH CPSI 65 adenotonsillectomy 65 PSQI 65 MMSE scores 65 comorbidity 65 Symptom severity 65 psychometric properties 65 carotid IMT 65 subscore 65 neurodevelopmental outcome 65 Physical Component 65 convergent validity 64 sociodemographic variables 64 premorbid 64 covariate 64 subclinical atherosclerosis 64 LUTS 64 Cognitive impairment 64 WOMAC pain 64 psychiatric morbidity 64 prognostic variables 64 logistic regression model 64 euthymic patients 64 sociodemographic characteristics 64 multivariate analyzes 64 comorbid depression 64 exploratory endpoints 64 sociodemographic factors 64 QOL 64 schizophreniform disorder 64 Sociodemographic 64 HIV HCV coinfected 64 interobserver 64 neuropsychiatric symptoms 63 clinically meaningful improvement 63 HADS 63 Brief Psychiatric 63 MADRS score 63 comorbidities 63 multivariable analysis 63 Comorbidities 63 inflammatory biomarkers 63 PANSS total 63 Logistic regression 63 psychopathological symptoms 63 erection hardness 63 Global Impression CGI 63 oncologic outcomes 63 chronicity 63 posttransplant 63 posttreatment 63 nondepressed 63 comorbid anxiety 63 depressive symptoms 63 neurocognitive functioning 63 preoperative PSA 63 BPS IC 63 Incontinence Impact Questionnaire 63 autonomic dysfunction 63 bivariate analysis 63 intraobserver 63 clinically meaningful improvements 63 polyarticular 63 Mental Component 63 dyspnoea 63 CPAP adherence 63 neuropsychological impairments 63 randomized controlled trials RCTs 63 Primary endpoints 63 Neuropsychiatric Inventory 62 Disease Activity 62 HDRS 62 CORE OM 62 bivariate analyzes 62 ADCS CGIC 62 Depressive Symptoms 62 multivariable analyzes 62 UPDRS motor 62 MetS 62 Main Outcome Measures 62 ADAS cog 62 perinatal outcomes 62 OAB symptoms 62 postoperative mortality 62 symptomatic VTE 62 pain subscale 62 Subgroup analyzes 62 Secondary endpoints 62 intact parathyroid hormone 62 HbA1C levels 62 serum lipid levels 62 neurodevelopmental outcomes 62 neurologic impairment 62 prognostic factors 62 APACHE II 62 odds ratios ORs 62 dyslipidaemia 62 subscores 62 Index CDAI 62 angiographically 62 IIEF 62 point Likert scale 62 Secondary efficacy endpoints 62 HOMA IR 62 function subscale 62 spirometric 62 interobserver reliability 62 HbA 1c levels 62 Rating Scale MADRS 62 UPDRS 61 Symptom Checklist 61 postoperative complication 61 extrapyramidal symptoms 61 cognitive affective 61 lipid profiles 61 DLQI 61 logistic regression models 61 nasal obstruction 61 subclinical hypothyroidism 61 daytime somnolence 61 PANSS scores 61 clinically meaningful reductions 61 Crohn Disease Activity 61 vesicoureteral reflux 61 SRBD 61 T1DM 61 overactive bladder symptoms 61 Comorbid 61 thyrotropin levels 61 NIHSS 61 Univariate analysis 61 myocardial viability 61 salivary cortisol 61 neurocognitive deficits 61 acetabular dysplasia 61 nonpharmacologic 61 multivariate logistic regression 61 NYHA functional class 61 EDSS score 61 Skin sterol 61 CDAI 61 comorbid disorders 61 symptomatology 61 euthymic 61 Multiple logistic regression 61 virological response 61 ADCS ADL 61 multivariable adjusted 61 #q# deletion syndrome 61 Child Behavior Checklist 61 ADAS Cog 61 PCWP 61 HbA 1c 61 Multivariate analysis 61 oxygen desaturation 61 retrospective cohort 61 urodynamic parameters 61 T2DM 61 Montgomery Asberg Depression 61 Socioeconomic status 61 multiple logistic regression 61 endometrial thickness 61 Epworth Sleepiness Scale 61 Seattle Angina Questionnaire 61 diastolic pressures 61 Scale EDSS score 61 adrenal function 61 atherogenic dyslipidemia 61 Charlson comorbidity index 61 meta regression 61 androgen deficiency 61 covariates 61 HbA 1C 61 Functional Assessment 61 cranial irradiation 61 WOMAC scores 61 antioxidant supplementation 61 Rating Scale BPRS 61 WOMAC TM 61 nonoperative treatment 61 GH deficiency 60 carotid stenosis 60 NIHSS score 60 reflux symptoms 60 Baseline characteristics 60 p = .# [002] 60 Dyspnea 60 serum PTH 60 International Prostate Symptom 60 nondiabetic patients 60 neurocognitive impairment 60 diabetes mellitus DM 60 DAS# [002] 60 PANSS 60 Expanded Disability Status 60 familial aggregation 60 NNT = 60 Apgar scores 60 Ocular Surface Disease 60 Comorbidity 60 Heritability 60 primary aldosteronism 60 prognostic indicators 60 DSM IV diagnoses 60 HAM D# 60 urinary symptoms 60 hypertension diabetes mellitus 60 Ejection Fraction 60 metabolite concentrations 60 anthropometric measures 60 Score DAS# 60 logistic regression analysis 60 etiologic 60 RLS symptoms 60 chromium picolinate supplementation 60 multivariate regression analysis 60 virologic response 60 EDSS scores 60 cardio respiratory fitness 60 ALT flares 60 transient elastography 60 echocardiographic parameters 60 comorbid psychiatric 60 suicide attempters 60 enthesitis 60 WOMAC 60 cardiac autonomic 60 shorter telomere length 60 affective psychosis 60 Multivariate analyzes 60 STN stimulation 60 Main Outcome Measure 60 Preoperatively 60 secondary efficacy endpoint 60 elevated ALT 60 untreated psychosis 60 comorbid illnesses 60 biochemical recurrence 60 generalized estimating 60 HER2 expression 60 Genetic variants 60 univariate 60 baseline HbA1c 60 hydroxyvitamin D levels 60 MDRD 60 urolithiasis 60 hematologic parameters 60 Unified Parkinson Disease 60 Endothelial function 60 systolic hypertension 60 hippocampal volume 60 antidepressant efficacy 60 tertiles 60 HAMD 60 Fibromyalgia Impact Questionnaire 60 lipid parameters 60 Meta analyzes 60 SF #v# 60 thromboprophylaxis 60 elevated creatinine 60 Subgroup analysis 60 LV ejection fraction 60 preoperatively 60 poststroke 60 #OHD 60 Multivariate logistic regression 60 Visual Analog Scale 60 Major Depressive Disorder 60 serum vitamin D 60 Score TOS 60 nonfatal MI 60 monoclonal gammopathy 60 CCyR 60 Bonferroni correction 60 syndromal 60 subjective sleepiness 60 Psoriasis Area 60 bronchial hyperresponsiveness 60 multivariate Cox 60 histological subtype 59 subthreshold depression 59 IRLS 59 Glasgow Coma Scale 59 plain radiographs 59 waist circumference WC 59 Prehypertension 59 genotypic resistance 59 AGHD 59 liver transplant recipients 59 CFQ R 59 diabetic polyneuropathy 59 airway responsiveness 59 Cardiorespiratory fitness 59 somatization disorder 59 longitudinal observational study 59 hsCRP levels 59 abdominal adiposity 59 chest radiographs 59 femoral neck fracture 59 nulliparous women 59 YMRS 59 radiographic findings 59 abnormal lipid 59 Treatment Outcome 59 hyperprolactinemia 59 Abnormal Involuntary Movement 59 conditional logistic regression 59 serum concentrations 59 coronary stenosis 59 PsA 59 daytime alertness 59 cognitive domains 59 tumor histology 59 pulmonary exacerbations 59 allele frequencies 59 methotrexate monotherapy 59 serum phosphate 59 serum IGF 59 ATACAND 59 PASI scores 59 psychiatric outpatients 59 oxycodone CR 59 Visual Analogue Scale VAS 59 perioperative complications 59 dopaminergic therapy 59 CTEPH 59 preoperative diagnosis 59 glycated hemoglobin levels 59 perioperative morbidity 59 albumin excretion rate 59 albumin excretion 59 symptom checklist 59 mRS 59 clinico pathological 59 DAS# CRP 59 estimated glomerular filtration 59 serum parathyroid hormone 59 intima media thickness 59 sociodemographic 59 asthma exacerbation 59 Postoperative 59 POAG 59 MDRD equation 59 cardiometabolic risk 59 hypoglycemic episodes 59 acetabular fractures 59 CI -#.# 59 histologic findings 59 ejection fractions 59 intracranial hypertension 59 virologic responses 59 Severe Primary IGFD 59 Lipodystrophy 59 Pain Intensity 59 decompensated cirrhosis 59 Visual acuity 59 generalized epilepsy 59 hallux valgus 59 Outcomes Study 59 nighttime awakenings 59 Non inferiority 59 venous thromboembolic disease 59 VLBW 59 haematologic 59 chronic prostatitis chronic 59 hypercalciuria 59 airway hyperresponsiveness 59 lowest tertile 59 % CI #.#-#.# [003] 59 confidence intervals CIs 59 nonobese 59 posttest 59 body habitus 59 HAQ 59 Negative Syndrome 59 morbidity mortality 59 Scale EDSS 59 postoperative AF 59 laboratory abnormalities 59 subsyndromal 59 IPAH 59 Functional Outcomes 59 Logistic regression models 59 coronary calcification 59 autistic traits 59 hypersomnia 59 pain catastrophizing 59 Cronbach alpha 59 co morbidities 59 Negative Symptoms 59 preintervention 59 confounder 59 BPRS 59 neuropsychological functioning 59 adverse perinatal 59 BEXXAR Therapeutic Regimen 59 antibody titer 59 left ventricular systolic 59 Sleep disordered breathing 59 neuropsychological assessment 59 Nocturia 59 peak VO2 59 left ventricular diastolic 59 PROactive study 59 chorioamnionitis 59 Scale PANSS 59 comorbid psychiatric disorders 58 QALYs 58 dyspnea 58 Multiple linear regression 58 Geriatric Depression 58 Acute Physiology 58 IPSS 58 extrapyramidal symptoms EPS 58 artery stenosis 58 SCr 58 neurologic complications 58 pCR 58 attention-deficit/hyperactivity disorder ADHD 58 beta blocker therapy 58 glomerular filtration 58 CLBP 58 aminotransferases 58 methacholine challenge 58 Generalized Anxiety Disorder 58 androgen deprivation 58 Suicidal ideation 58 Kaplan Meier curves 58 fasting insulin 58 Difficulties Questionnaire 58 seropositivity 58 genetic polymorphisms 58 prevalences 58 daytime sleepiness 58 cerebral perfusion 58 neurosensory 58 pyridostigmine 58 hemodynamics 58 guideline concordant 58 STRIDE PD 58 CIMZIA TM certolizumab pegol 58 β blockers 58 comorbid diagnoses 58 ANCOVA 58 microscopic hematuria 58 obstructive CAD 58 fasting plasma 58 SELENA SLEDAI 58 hemodynamic parameters 58 coinfected patients 58 affective psychoses 58 pharmacodynamic parameters 58 pulmonary capillary wedge 58 proband 58 pathophysiological mechanisms 58 systolic dysfunction 58 undetectable HBV DNA 58 postprocedure 58 % CI #.#-#.# [006] 58 glycated hemoglobin 58 juvenile idiopathic arthritis JIA 58 Hemoglobin A1c 58 DSM IV diagnosis 58 clinicopathological 58 affective disorders 58 morphometric vertebral fractures 58 neurodevelopmental impairment 58 syndromic 58 Heavy menstrual bleeding 58 Cystatin C 58 nontraumatic 58 QIDS SR 58 habitual snoring 58 TEAEs 58 Status Scale EDSS 58 bronchopulmonary dysplasia BPD 58 hepatic lesions 58 serum leptin 58 GERD symptom 58 methodologic 58 somatic symptom 58 Outcome Measures 58 ELBW 58 CONCERTA ® 58 NAbs 58 erythrocyte sedimentation rate 58 neurological abnormalities 58 subtrochanteric 58 recurrent miscarriage 58 obstructive coronary artery 58 hypochondriasis 58 prespecified secondary 58 elevated triglyceride levels 58 CNS LS 58 bivariate 58 subsyndromal depression 58 poststroke depression 58 Pearson correlation coefficients 58 CRQ 58 ADHD RS 58 telomere lengths 58 APOE e4 58 elevated IOP 58 FeNO 58 Major depressive disorder 58 baseline LDH 58 familial clustering 58 CR nPR 58 juvenile idiopathic arthritis 58 transferrin saturation 58 univariate analysis 58 hip BMD 58 NNRTI resistance 58 actigraphy 58 arterial oxygen saturation 58 variceal bleeding 58 leucopenia 58 SSc 58 comorbid 58 CSBMs 58 Primary IGFD 58 prostate cancer CaP 58 HbA1c levels 58 -#.# ± [002] 58 postintervention 58 nonadherence 58 GH deficient 58 pelvic lymphadenectomy 58 Hp2 2 58 P = .# 58 Regression analyzes 58 Oswestry Disability Index 58 Kaplan Meier analysis 58 tibiofemoral 58 parkinsonian symptoms 58 plasma homocysteine 58 aetiology 58 aldosterone antagonist 58 microalbuminuria 58 tissue oxygenation 58 parkinsonian 58 neurological sequelae 58 gastroduodenal 58 somatoform disorders 58 serum markers 58 glycosylated hemoglobin HbA1c 58 morbidities 58 SGPT 58 clinicopathologic 58 PREZISTA r arm 58 glycated hemoglobin HbA1c 58 acetabular fracture 58 nonfasting triglyceride levels 58 lipid lowering agents 58 Complications Trial 58 eculizumab therapy 58 tic severity 57 prospectively defined 57 hyper IgE syndrome 57 plasma cortisol 57 postdischarge 57 preserved ejection fraction 57 renal cysts 57 nonexposed 57 serum GGT 57 nasal symptom 57 Score IPSS 57 dizziness nausea diarrhea 57 Alzheimer Disease Assessment 57 subtests 57 lipid abnormalities 57 serum testosterone 57 neuropsychological deficits 57 = #.#-#.# 57 rhinoconjunctivitis 57 glomerular filtration rate 57 internalizing disorders 57 interobserver agreement 57 serum retinol 57 HeFH 57 prolactin levels 57 adnexal mass 57 DAS# scores 57 predictive validity 57 acute myocardial infarction MI 57 Insulin sensitivity 57 surrogate markers 57 emotional lability 57 Randomized Controlled Trials 57 CVD mortality 57 KRAS status 57 ICD shocks 57 internalizing behaviors 57 silent myocardial ischemia 57 anemia hemoglobin 57 thromboembolic complications 57 atrioventricular block 57 graft dysfunction 57 atopy 57 baseline PASI 57 VUR 57 NHANES III 57 syncopal episode 57 estimated GFR 57 F FDG PET 57 apnea hypopnea index 57 CP CPPS 57 hsCRP 57 prognostic significance 57 alanine aminotransferase ALT 57 post thrombotic syndrome 57 plasma leptin 57 umol L 57 hepatorenal syndrome 57 allostatic load 57 CHADS2 57 FOLPI 57 SNHL 57 visceral metastases 57 recurrent venous thromboembolism 57 overt hypothyroidism 57 ALS Functional 57 neurologic symptoms 57 VFQ 57 A1c levels 57 Distress Scale 57 histologically proven 57 Fecal Incontinence 57 Nesiritide 57 lymphocyte count 57 hyperglycaemia 57 adrenalectomy 57 NIS LL 57 glycemic variability 57 urinary tract symptoms 57 cardiac malformations 57 macrovascular disease 57 Cognitive Impairment 57 % CI #.#-#.# [008] 57 BPH symptom 57 meta analytic 57 thiopurine 57 intraclass correlation coefficients 57 FDG PET scans 57 gait disturbance 57 timepoints 57 parasitological 57 Postoperative complications 57 schizophrenia schizoaffective disorder 57 Female Sexual Function 57 Observational studies 57 pharmacologic intervention 57 NPH insulin 57 tipranavir r 57 impaired cognition 57 RE LY ® 57 LV dysfunction 57 pericardial effusion 57 Proteinuria 57 androgen depletion 57 serum calcium levels 57 Efficacy endpoints 57 MMSE 57 macroalbuminuria 57 PSADT 57 Univariate 57 acute subacute 57 mammographic density 57 #OHD levels 57 Renal dysfunction 57 pharmacologic treatments 57 neurologic outcomes 57 % CI #.#-#.# [007] 57 dyspareunia 57 THIS STUDY 57 hemodynamic measurements 57 COPD exacerbation 57 Erectile Function IIEF 57 Fasting glucose 57 alanine aminotransferase 57 anal incontinence 57 intelligence quotient IQ 57 chronic prostatitis 57 QALE 57 unmeasured confounders 57 elevated bilirubin 57 sonographic findings 57 intraclass correlation coefficient 57 Echocardiographic 57 hemoglobin A1c levels 57 atrophic gastritis 57 LDL HDL 57 p = #.# [003] 57 Sleep disturbances 57 Y BOCS 57 neurocognitive 57 rheumatic disorders 57 clinicopathological features 57 fractional anisotropy 57 Genetic predisposition 57 UGT#A# * 57 Rating Scale UPDRS 57 somatic complaints 57 knee OA 57 Descriptive statistics 57 renal scarring 57 ECLS 57 detrusor overactivity 57 postoperative pulmonary 57 concomitant medications 57 serum folate concentrations 57 neurologic deficits 57 Exacerbations 57 non menstrual pelvic 57 APOE ε4 57 logistic regression 57 plasma homocysteine levels 57 thrombophilia 57 hypercholesterolaemia 57 FDG PET imaging 57 arterial thickening 57 calculated creatinine clearance 57 overnight polysomnography 57 lifetime abstainers 57 differential gene expression 57 ejaculatory function 57 mTSS 57 prospective multicenter study 57 SLNB 57 Mood disorders 57 Longitudinal studies 57 vasomotor 57 MoxDuo TM IR 57 serum estradiol 57 Neuropsychiatric Inventory NPI 57 plasma pharmacokinetics 57 lower extremity amputation 57 biopsy Gleason 57 Severity Index 57 Score DAS 57 Poisson regression 57 AST ALT 57 elevated LDH 57 nonsevere 57 dietary calcium intake 57 nonpregnant women 57 recurrent VTE 57 transaminase elevations 57 DSM IV SCID 57 CSF biomarkers 57 ski lls 57 multivariable logistic regression 57 CHADS 57 inhaled corticosteroid therapy 57 Severity Index PASI 57 TT genotype 57 glycemia 57 neutropaenia 57 mL/min/#.# m 2 57 coronary artery calcification 57 antidiabetic medication 57 renal allograft 57 treat NNT 57 dysfunctional voiding 57 bacterial prostatitis 57 Exclusion criteria 57 apolipoprotein B 57 aminotransferase levels 57 TNF antagonist 57 MADRS 57 androgen excess 57 oral anticoagulant therapy 56 Urogenital Distress Inventory 56 tryptophan depletion 56 hyperhomocysteinemia 56 antiphospholipid antibodies 56 FACIT 56 FACIT Fatigue 56 episodic migraine 56 State Examination MMSE 56 d dimer 56 cortical atrophy 56 exhaled nitric oxide 56 neovascular glaucoma 56 interpersonal psychotherapy 56 5 HTTLPR 56 hemoglobin A1c HbA1c 56 isolated systolic hypertension 56 nonvertebral fractures 56 serum lipids 56 percutaneous vertebroplasty 56 serum cortisol 56 QTc intervals 56 plasma glucose concentration 56 ELBW infants 56 extensive metabolizers 56 PLMs 56 Interrater reliability 56 gastro esophageal reflux 56 LVEF 56 Orthostatic Hypotension 56 neuropsychological assessments 56 coinfection 56 abdominal circumference 56 NATRECOR ® 56 testosterone supplementation 56 hypoglycemic events 56 electrophysiologic 56 nmol L. 56 thromboembolic 56 OSDI 56 mucosal inflammation 56 systolic BP 56 Mortality Risk 56 QOL questionnaire 56 metabolic syndrome MetS 56 â ‰ ¥ 56 Iron Deficiency Anemia 56 psychosocial distress 56 Scale Cognitive Subscale 56 Renal Function 56 QTc prolongation 56 adjuvant systemic 56 serum ferritin 56 glycosylated hemoglobin 56 #F FDG PET 56 femoral neck BMD 56 angiographic outcomes 56 visceral adiposity 56 serum selenium 56 Sjögren syndrome 56 ± SD 56 serum uric acid 56 hypogonadotropic hypogonadism 56 solifenacin 56 Structured Clinical 56 aspartate aminotransferase AST 56 IRLS score 56 thyroid dysfunction 56 tertile 56 cerebral microbleeds 56 NSQIP 56 elevated serum creatinine 56 handgrip strength 56 distal radial fractures 56 IELT 56 fasting glucose levels 56 #.#ng/ml 56 Parkinson Disease PD 56 voiding dysfunction 56 SSRI SNRI 56 Index HAQ DI 56 sensory neuropathy 56 sd = 56 explanatory variables 56 parkinsonism 56 neuropsychological 56 HBeAg negative 56 UPDRS Part III 56 highest tertile 56 carotid intima media 56 predisposing factor 56 multi infarct dementia 56 REYATAZ ritonavir 56 EXJADE 56 cerebral oxygenation 56 varus deformity 56 pathogenetic mechanisms 56 hematological parameters 56 STEP BD 56 neurocognitive outcomes 56 neurologic sequelae 56 confounding variables 56 attain statistical significance 56 Cognitive Function 56 hypovitaminosis D 56 URTI 56 postmenopausal osteoporotic women 56 transvaginal sonography 56 hydroxyvitamin D concentrations 56 multivariate adjustment 56 atopic 56 mesalamine granules 56 pathologic fractures 56 Histologic 56 serum folate 56 myocardial fibrosis 56 serum aminotransferase levels 56 underdiagnosis 56 hematopoietic cancers 56 analgesic efficacy 56 EDSS 56 oxcarbazepine 56 nephrolithiasis 56 cryptogenic 56 nonarteritic anterior ischemic optic 56 Hyperlipidemia 56 clinical endpoints 56 BPH LUTS 56 β = 56 Symptom Severity 56 pressor response 56 Diagnostic Criteria 56 Erectile function 56 micronutrient supplementation 56 inhaled budesonide 56 HSCT 56 knee osteoarthritis OA 56 thyrotropin 56 Uncontrolled hypertension 56 Dysmenorrhea 56 behavioral disinhibition 56 potentially modifiable 56 Psychosomatic Research 56 corticosteroid dose 56 nodal metastases 56 creatinine ratio 56 plasma lipids 56 treatment emergent AEs 56 anthropometric measurements 56 amnestic MCI 56 prucalopride 56 Candesartan 56 atherothrombotic 56 sonographic diagnosis 56 nmol l 56 noncardiac 56 CDAI score 56 variance ANOVA 56 aneurysmal subarachnoid hemorrhage 56 troponin T 56 causal pathway 56 CRp 56 aromatase inhibitor therapy 56 hypogonadal 56 androgen suppression 56 ECOG PS 56 NATRECOR R 56 leukocyte counts 56 REYATAZ r arm 56 Physical Function 56 impaired glucose metabolism 56 sensitivity specificity 56 bronchopulmonary dysplasia 56 hemodialysis patients 56 dysuria 56 plasma folate 56 NOMID 56 haemodynamic 56 semistructured interview 56 Severity MSCS score 56 potential confounders 56 structural abnormalities 56 EGFR mutation status 56 isoprostane 56 secondary efficacy endpoints 56 rheumatoid factor 56 viral etiology 56 reflux esophagitis 56 mg BID dose 56 pretest probability 56 left ventricular LV 56 GERD symptoms 56 diagnosing ADHD 56 Acute Myeloid Leukaemia AML 56 osteoarthritic